Zimmer Biomet Holdings, Inc. Reports Fourth Quarter and Full-Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Needham & Company Raised Price Target on Zimmer Biomet Holdings (ZBH) Following Mixed 4Q Results
January 28, 2016 1:25 PM ESTNeedham & Company reiterated a Buy rating on Zimmer Holdings (NYSE: ZBH), and raised the price target to $129.00 (from $127.00), following the company's 4Q earnings report. Revenue was $1.934B, missing consensus estimates of $1.954B. And EPS was $2.09, beating out the consensus of $2.04.
Analyst Mike Matson... More
Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c
January 28, 2016 7:36 AM ESTZimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.09, $0.05 better than the analyst estimate of $2.04. Revenue for the quarter came in at $1.98 billion versus the consensus estimate of $1.96 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2016 EPS of $7.80-$7.95, versus the... More



